Trials / Unknown
UnknownNCT01168505
Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients
The Role of Intravenous Iron to Prevent Anemia in Women With Breast Cancer Receiving (Neo)Adjuvant Chemotherapy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Instituto do Cancer do Estado de São Paulo · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study to evaluate the efficacy of intravenous iron supplementation in the prevention of anemia in patients receiving (neo)adjuvant breast cancer regimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ferric hydroxide saccharate | single dose of 200 mg (2 ampoules), 24-48 hours after administration of chemotherapy for a total of four doses |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2010-07-23
- Last updated
- 2014-05-21
Locations
2 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01168505. Inclusion in this directory is not an endorsement.